Therapeutical influence on the severity of acute pancreatitis;Therapeutische beeinflussung des schweregrads der akuten pankreatitis

Chirurgische Gastroenterologie Interdisziplinar

Volumn 15, Issue 4, 1999, Pages 328-333

  Werner, J ^a   Klar, E ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Acute pancreatitis: treatment (experimental, clinical, conservative management)

Indexed keywords

ANTIBIOTIC AGENT; DEXTRAN; ENDOTHELIN RECEPTOR ANTAGONIST; INTERCELLULAR ADHESION MOLECULE 1; NITRIC OXIDE;

ACUTE PANCREATITIS; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; CLINICAL FEATURE; DISEASE SEVERITY; HUMAN; REVIEW; TREATMENT PLANNING;

EID: 0038105296     PISSN: 01779990     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Steer M, Saluja A: Experimental acute pancreatitis: Studies of the early events that lead to cell injury; in Go V, DiMagnio EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA (eds): The Pancreas: Biology, Pathology and Disease. New York, Raven, 1995, pp 489-550.
2. Pitchumoni CS, Agarwal N, Jain NK: Systemic complications of acute pancreatitis. Am J Gastroenterol 1988;83:597-604.
3. Karanjia ND, Widdison AL, Lutrin FJ, Reber HA: Dopamine in models of acute pancreatitis. Gut 1994;35:547-553.
4. Klar E, Rattner DW, Compton CC, Stanford G, Chernow B, Warshaw AL: Adverse effects of therapeutic vasoconstrictors in experimental acute pancreatitis. Ann Surg 1991;325:382-387.
5. Tenner S, Banks PA: Acute pancreatitis: Nonsurgical management. World J Surg 1997;21:143-148.
6. Klar E: Hemodilution and hemofiltration in severe acute pancreatitis; in Büchler MW, Uhl W, Friess H (eds): Acute Pancreatitis: Novel Concepts in Biology and Therapy. Berlin, Blackwell, 1999, pp 423-428.
7. Naeije R, Salingret E, Clumeck N, DeTroyer A, Devis G: Is nasogastric suction necessary in acute pancreatitis? Br Med J 1978;2:659-660.
8. Sarr MG, Sanfey H, Cameron JL: Prospective, randomized trial of nasogastric suction in patients with acute pancreatitis. Surgery 1986;100:500-504.
9. D'Amico D, Favia G, Biassiato R, Cassacia M, Falcone F: The use of somatostatin in acute pancreatitis: Results of a multicenter trial. Hepatogastroenterology 1990;37:92-96.
10. Uhl W, Malfertheiner P, Adler G, Bruch HP, Lankisch PG: A randomized controlled multicentric trial on the role of octreotide in human acute pancreatitis. Gastroenterology 1997; 112:488.
11. Trapnell JE, Ribgby CC, Talbot CH, Duncan EH: A controlled trial of Trasylol in the treatment of acute pancreatitis. Br J Surg 1974; 61:177-182.
12. Imrie CW, Benjamin IS, Ferguston JC, McKay AJ, Mackenzie I: A single centre double blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg 1978;65:337-341.
13. Goebel H, Ammann R, Herfarth C: A double blind trial of synthetic salmon calcitonin in the treatment of acute pancreatitis. Scand J Gastroenterol 1978;14:881-884.
14. Freise J, Melzer F, Schmidt W, Horbach L: Gabexate mesilate in der Behandlung der akuten Pankreatitis. Z Gastroenterol 1986;24:200-211.
15. Büchler MW, Malfertheiner P, Uhl W, Schölmerich J, Stöckmann F: Gabexate mesilate in acute pancreatitis. Gastroenterology 1993;104:1165-1170.
16. Pederzoli P, Cavallini G, Falconi M, Bassi C: Gabexate mesilate versus aprotinin in human acute pancreatitis. Int J Pancreatol 1993;14:117-123.
17. Cavallini G, Tittobello A, Frulloni L, Masci E, Mariani A, Di Franszesco V: Gabexate for the prevention of pancreatic damage related to endoscopic cholangiography. N Engl J Med 1996;335:919-923.
18. Mayer AD, McMahon MJ, Corfield AP, Cooper MJ, Williamson CN: Controlled clinical trial of peritoneal lavage for the treatment of severe acute pancreatitis. N Engl J Med 1985;312:399-404.
19. Ranson JH, Berman RS: Long peritoneal lavage decreases pancreatic sepsis in acute pancreatitis. Ann Surg 1990;211:708-718.
20. Beger HG, Bittner R, Büchler MW: Hemodynamic data pattern in patients with acute pancreatitis. Gastroenterology 1986;90:74-79.
21. Schmidt J, Huch K, Mithöfer K, Sinn P, Buhr HJ, Warshaw AL, Herfarth C, Klar E: Benefits of various dextrans after delayed therapy in necrotizing pancreatitis of the rat. Intensive Care Med 1996;22:1207-1213.
22. Werner J, Schmidt J, Langer C, Gebhard MM, Herfarth C, Klar E: Superiority of dextran compared to crystalloids and other colloids in the treatment of acute necrotizing pancreatitis. Pancreas 1995;11:452.
23. Klar E, Messmer K, Warshaw AL, Herfarth C: Pancreatic ischemia in experimental acute pancreatitis: Mechanism, significance and therapy. Br J Surg 1990;77:1205-1210.
24. Klar E, Foitzik T, Buhr H, Messmer K, HerfarthC: Isovolemic hemodilution with dextran 60 as treatment of pancreatic ischemia in acute pancreatitis. Ann Surg 1993;217:369-374.
25. Isemann MR, Büchler MW, Uhl W, Malfertheimer P, Beger HG: Pancreatic necrosis develops within 96 hours. Digestion 1996;46:145-152.
26. Arfors KE, Buckley PB: Role of artificial colloids in rational fluid therapy; in Tuma RF, White JV, Messner K (eds): The Role of Hemodilution in Optimal Patient Care. München, Zuckerschwerdt, 1993, p 100.
27. Messmer K: Acceptable hematocrit levels in surgical patients. World J Surg 1987;11:41.
28. Klar E, Herfarth C, Messmer K: Therapeutic effect of isovolemic hemodilution with Dextran 60 on the impairment of pancreatic microcirculation in acute biliary pancreatitis. Ann Surg 1990;211:346-349.
29. Klar E, Mall G, MessmerK, Herfarth C: Improvement of impaired pancreatic microcirculation by isovolemic hemodilution protects pancreatic morphology in acute biliary pancreatitis. Surg Gynecol Obstet 1993;176:144-151.
30. Werner J, Schmidt J, Gebhard MM, Herfarth C, Klar E: Überlegenheit von Dextran gegenüber HAES und Kristalloiden in der Leukozyten-Endothel-Interaktion bei experimenteller Pankreatitis. Langenbecks Arch Chir 1996;suppl 1:469-472.
31. Werner J, Secchi A, Schmidt J, Gebhard MM, Herfarth C, Klar E: Dextran may lower septic complications in necrotizing pancreatitis. Gastroenterology 1997;112:A1485.
32. Hughes CB, Grewal HP, Gaber LW, Kotb M, Mann L, Gaber AO: Anti-TNF therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat. Am J Surg 1996;171:274-280.
33. Denham W, Yang J, Fink G, Denham D, Carter G, Ward K, Norman J: Gene targeting demonstrates additive detrimental effects of interleukin 1 and tumor necrosis factor during pancreatitis. Gastroenterology 1997;113:1741-1746.
34. Rongione AJ, Kusske AM, Kwan K, Ashley SW, Reber HA, McFadden DW: Interleukin 10 reduces the severity of acute pancreatitis in rats. Gastroenterology 1997;112:960-967.
35. Formela LJ, Wood LM, Whittaker M, Kingsnorth AN: Amelioration of experimental acute pancreatitis with a potent platelet-activating factor antagonist. Br J Surg 1994;81:1783-1785.
36. Rivera JA, Werner J, Warshaw AL, Lewandrowski KB, Rattner DW, Fernandez-del Castillo C: Lexipafant fails to improve survival in severe necrotizing pancreatitis in rats. Int J Pancreatol 1998;23:101-106.
37. McKay CJ, Curran F, Sharples C, Baxter N, Imrie CW: Prospective placebo-controlled randomized trial of lexipafant in predicted severe acute pancreatitis. Br J Surg 1997;84:1239-1243.
38. Filep JP, Födes-Filep E, Rousseau A, Sirois P, Fournier A: Vascular responses to endothelin-1 following inhibition of nitric oxide synthesis in the conscious rat. Br J Pharmacol 1993; 110:1213-1221.
39. Foitzik T, Faulhaber J, Hotz HG, Kirchengast M, Buhr HJ: Endothelin-1 triggert die Ausbildung der schweren akuten Pankreatitis. Langenbecks Arch Chir 1997;1:749-753.
40. Molero X, Guarner F, Salas A, Mourelle M, Puig V, Malagelada JR: Nitric oxide modulates pancreatic basal secretion and response to caerulein in the rat. Gastroenterology 1995;108:1855-1862.
41. Werner J, Rivera J, Fernandez-del Castillo C, Warshaw AL: Differing roles of nitric oxide in the pathogenesis of acute edematous versus necrotizing pancreatitis. Surgery 1997;121:23-30.
42. Springer T: Adhesion receptors of the immune system. Nature 1990;345:425-434.
43. Pober JS, Cotran RS: The role of endothelial cells in inflammation. Transplantation 1990; 50:537-544.
44. Werner J, Z'graggen K, Fernandez-del Castillo C, Lewandrowski KB, Compton CC, Warshaw AL: Specific therapy for local and systemic complications of acute pancreatitis with monoclonal antibodies against ICAM-1. Ann Surg 1999; 229:834-842.
45. Werner J, Hartwig W, Schmidt E, Gebhard MM, Herfarth C, Klar E: Reduktion lokaler und systemischer Komplikationen der akuten Pankreatitis durch monoklonale Antikörper gegen ICAM-1. Langenbecks Arch Chir 1998;1:725-729.
46. Werner J, Hartwig W, Schmidt J, Herzog L, Köppel T, Sinn P, Gebhard MM, Herfarth C, Klar E: Monoclonal antibodies against ICAM-1 reduce leukocyte infiltration and prevent septic complications in acute pancreatitis. Digestion 1998; 59:228.
47. Ryan CM, Schmidt J, Lewandrowski J, Compton CC, Rattner DW, Warshaw AL: Gut macromolecular permeability in pancreatitis correlates with severity of disease in rats. Gastroenterology 1993;104:890-897.
48. Hall JC, Heel K, McCauley R: Glutamine (review). Br J Surg 1996;83:305-322.
49. Wilmore DW: Glutamine and the gut. Gastroenterology 1994;107:1885-1889.
50. Bassi C, Falconi M, Caldiron E, Salvia R, Bertazzoni ME, Pederzoli P: Use of antibiotics in necrotizing pancreatitis. Probl Gen Surg 1997; 13:80-85.
51. Beger HG, Bittner R, Block S, Büchler MW: Bacterial contamination of pancreatic necrosis. Gastroenterology 1986;91:433-438.
52. Johnson CD: Antibiotic prophylaxis in severe acute pancreatitis. Br J Surg 1996;83:883-884.
53. Foitzik T, Fernandez-del Castillo C, Rattner DW, Warshaw AL: Pathogenesis and prevention of early pancreatic infection in experimental acute necrotizing pancreatitis. Ann Surg 1995;222:179-185.
54. Mithöfer K, Fernandez-del Castillo C, Ferraro MJ, Lewandrowski KB, Warshaw AL: Antibiotic treatment improves survival in experimental acute necrotizing pancreatitis. Gastroenterology 1996;110:232.
55. Pederzoli P, Bassi C, Vesentini S, Campedelli A: A multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg Gynecol Obstet 1993;176:480-483.
56. Sainio V, Kemppainen E, Puolakkainen P, Taavitsainen M, Kivisaari L: Early antibiotic treatment in acute necrotizing pancreatitis. Lancet 1995;346:663-667.
57. Takeda K, Matsuno S, Sunamura M, Kakugawa Y: Continuous regional arterial infusion of protease inhibitor and antibiotics in acute necrotizing pancreatitis. Am J Surg 1996;171:394-398.
58. Delcenserie R, Yzet T, Ducoix JP: Prophylactic antibiotic in treatment of severe acute alcoholic pancreatitis. Pancreas 1996;13:198-201.
59. Luiten EJT, Hop WJC, Lange JF, Bruining H: Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis. Ann Surg 1995;222:57-65.
60. Schwarz M, Büchler M, Isenmann R, Meyer H, Beger HG: Antibiotika bei nekrotisierender Pankreatitis. Dtsch Med Wochenschr 1997; 122:356-361.
61. Stoutenbeck CP, VanSaene HKF, Miranda DR, Zandra DF: The effect of selective decontamination of the digestive tract on colonization and infection rate in multiple trauma patient. Intensive Care Med 1984;10:185.
62. Devernis C, Johnson CD, Bassi C, Bradley E, Imrie CW, McMahon MJ, Modlin I: Diagnosis, objective assessment of severity, and management of acute pancreatitis. Int J Pancreatol 1999;25:195-210.
63. Sax HC, Warner BW, Talamini MA, Hamilton FN, Bell RH, Bower RH: Early total parenteral nutrition in acute pancreatitis: Lack of beneficial effects. Am J Surg 1987;153:117-123.
64. Sitzmann JV, Steinborn PA, Zinner J, Cameron JL: TPN and alternative substrates in the treatment of severe acute pancreatitis. Surg Gynecol Obstet 1989;168:311-317.
65. Kalfarentzos F, Kehagias J, Mead N, Kokkinis K, Gogos CA: Enteral feeding is superior to parenteral nutrition in severe acute pancreatitis. Br J Surg 1997;84:1665-1669.